NCT07479433 The NAVIGATE-PCI Registry: A New Approach to VIew CT-derived Guidance Ahead of Stenting To Plan Efficient PCI
| NCT ID | NCT07479433 |
| Status | Recruiting |
| Phase | — |
| Sponsor | HeartFlow, Inc. |
| Condition | Coronary Artery Disease (CAD) |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2026-03-11 |
| Primary Completion | 2026-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2026-03-11 with a primary completion date of 2026-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of Heartflow's NAVIGATE-PCI Registry is to collect observational data about the management of patients before and after deployment of Heartflow's PCI Navigator.
Eligibility Criteria
Inclusion Criteria (all must be present): 1. CCTA completed ≤90 days prior to elective PCI with acceptable image quality according to Heartflow's image quality requirements 2. Referred for elective PCI 3. Clinically stable without symptoms suggestive of acute coronary syndrome (ACS) at the time of the intervention Exclusion Criteria (all must be present): 1. ED presentation (at the time of the referral for PCI) 2. Previous coronary artery bypass graft (CABG) 3. Planned intervention in a previously stented vessel territory 4. Acute chest pain (in patients who have not been ruled out for ACS) 5. Participating in a conflicting study being undertaken during the PCI
Contact & Investigator
Ziad Ali, MD, DPhil
PRINCIPAL INVESTIGATOR
St. Francis Hospital & Heart Center Columbia University
Frequently Asked Questions
Who can join the NCT07479433 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Coronary Artery Disease (CAD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07479433 currently recruiting?
Yes, NCT07479433 is actively recruiting participants. Contact the research team at adoctolero@heartflow.com for enrollment information.
Where is the NCT07479433 trial being conducted?
This trial is being conducted at Marietta, United States.
Who is sponsoring the NCT07479433 clinical trial?
NCT07479433 is sponsored by HeartFlow, Inc.. The principal investigator is Ziad Ali, MD, DPhil at St. Francis Hospital & Heart Center Columbia University. The trial plans to enroll 5,000 participants.